Belfast tech firm secures £225,000 research grant for anxiety and PTSD treatments

Neurovalens develops medical devices that deliver electrical stimulation to deep parts of the brain and nervous system

The new research and development grant of £225,000 was provided by Invest Northern Ireland. Picture: Neurovalens

Neurovalens, a health tech start-up based in Belfast and San Diego, has secured £225,000 (€265,000) in additional funding for the development of treatments for anxiety, insomnia and PTSD using non-invasive neurostimulation.

The company’s medical devices deliver electrical stimulation to deep parts of the brain and nervous system in a bid to treat various neurological ailments without the need for implanted electrodes.

The new research and development grant was provided by Invest Northern Ireland. It will ...